| Authors: |
O'Leary B; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Breast Unit, Royal Marsden Hospital, London, UK., Cutts RJ; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Huang X; Pfizer, New York, NY, USA., Hrebien S; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Liu Y; Pfizer, New York, NY, USA., André F; Department of Medical Oncology, Institut Gustave Roussy, Université Paris Sud, Villejuif, France., Loibl S; German Breast Group, Martin Behaim-Strasse 12, Neu-Isenburg, Germany., Loi S; Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia., Garcia-Murillas I; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Cristofanilli M; Robert H Lurie Comprehensive Cancer Centre, Feinberg School of Medicine, Chicago, IL, USA., Bartlett CH; Pfizer, New York, NY, USA., Turner NC; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Breast Unit, Royal Marsden Hospital, London, UK. |
